Diagnosis

Pityriasis versicolor

A benign superficial chronic fungal infection usually characterized by hypopigmented or hyperpigmented macules and patches on the chest and the back.

Also known as: Tinea versicolor

Etiology

Cause [a83]

Pathophysiology [a83]

  1. Malassezia is a fungal inhabitant of the normal skin flora present on healthy skin (oily regions: face, scalp, and back)

  2. Not contagious

  3. Unknown host trigger --> Malassezia transforms into its pathogenic filamentous form --> can cause tinea versicolor

Risk factors [a83]

Epidemiology

Incidence per 100.000 [a83][arn][vpi][ef7][dys]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

None listed.

Clinical findings

None listed.

Anamneses

None listed.

Localized findings

Rash
Radiates
CaputCollumThoraxAbdomenGenitalArmBackLower body
Distribution
AsymmetricLocalizedMultipleSingle
Lesion type
ErythemaHyperpigmentationHypopigmentationMaculePapulePlaquePustuleScale
Color
BrownRedWhite
Associated symptom
Itch

Approach

Treatment

  1. Topical treatment: [a83][arn]

    • Ketoconazole 2% shampoo for 3 days

    • Selenium sulfide 2.5% shampoo or lotion applied for 10 minutes daily for 1 week

    • Terbinafine 1% once or twice daily from 1 to 4 weeks

    • Ciclopirox 1% applied twice daily for 2 weeks

    • Zinc pyrithione 1% daily for 5 minutes for 2 weeks

    • Ultraviolet UV-B phototherapy (limited evidence)

  2. Oral therapy: if resistant to topical treatment or with widespread disease

    • Itraconazole 200 mg daily for 7 days

    • Fluconazole 300 mg weekly for 2 weeks

  3. Prophylaxis:

    • Topical selenium sulfide 2.5% or ketoconazole 2% shampoo applied to the entire body for ten minutes once per month

    • Oral Itraconazole 200 mg twice daily, once each month

Differential diagnoses

Candidiasis, Eczema, Erythrasma, Folliculitis, Mycosis fungoides, Pityriasis alba, Pityriasis rosea, Psoriasis, Seborrheic dermatitis, Syphilis, Tinea, Tinea corporis, Vitiligo


References

[1] Karray M, McKinney WP. Tinea Versicolor. Updated 2024 Feb 12: https://www.ncbi.nlm.nih.gov/books/NBK482500/

[2] http://emedicine.medscape.com/article/1091575; [Medscape]

[3] Mahmoudabadi A Z, Mossavi Z, Zarrin M. Pityriasis versicolor in Ahvaz, Iran. Jundishapur J Microbiol. 2009;2(3): 92-96.

[4] Borelli D, Jacobs PH, Nall L. Tinea versicolor: epidemiologic, clinical, and therapeutic aspects. J Am Acad Dermatol. 1991 Aug;25(2 Pt 1):300-5.

[5] He SM, Du WD, Yang S, Zhou SM, Li W, Wang J, Xiao FL, Xu SX, Zhang XJ. The genetic epidemiology of tinea versicolor in China. Mycoses. 2008 Jan;51(1):55-62.

Scroll to top